Single-dose radiotherapy for breast cancer confirmed to be suitable for most patients: Results from further analysis of the large international TARGIT-A trial led from University College London brings more good news for patients diagnosed with breast cancer. Four important questions have been answered by this new analysis.

May 27, 2021

TARGIT-IORT is a pioneering breast cancer therapy developed by UCL clinicians, which requires just one shot of radiotherapy. With TARGIT-IORT therapy, eight out of every ten patients have no need for any further post-operative radiotherapy treatments. 

 

View the full article HERE

 

 

Single-Dose Radiation Therapy for Breast Cancer Removes Treatment
Barriers for Underserved Black Women

TARGIT Collaborative Group Advocates Wider Adoption of TARGIT-IORT to Address Racial
Disparities and Reduce Compliance Issues

February 18, 2021

SACRAMENTO, Calif.,  (GLOBE NEWSWIRE) — Black women experience longer
breast cancer treatment times and may have less access to essential radiation technology,
according to a recent study published in the journal Cancer. 1 In response, the TARGIT
Collaborative Group (TCG), a national cancer advocacy organization of doctors and scientists
working to improve cancer patient care, endorses single-dose radiation as a potential solution
to address barriers to care that disproportionately affect black women with early-stage breast
cancer in the United States.

 

View the full article HERE

 

 

First in Mississippi: Breast cancer single dose radiation to reduce length of treatments

Posted January 29, 2021

WLBT-3 TV On Your Side – Jackson, Mississippi

Less intense breast cancer radiation treatment, practiced in Europe for two decades, is now available here in Mississippi.

View the full article HERE

 

 

Single-dose radiation therapy treating early-stage breast cancer

Posted January 27, 2021

Madison County Journal – Madison County, Mississippi

Merit Health Women’s Hospital is the first hospital in Mississippi to offer single-dose intraoperative radiotherapy for qualifying early-stage breast cancer patients.

View the full article HERE

 

Miss. hospital offers single-dose radiation therapy for breast cancer patients

Posted January 22, 2021

WLBT-3 TV On Your Side  – Jackson, Mississippi

Merit Health Woman’s Hospital in Flowood is offering a new treatment of single-dose radiation therapy for qualifying early-stage breast cancer patients.

View the full article HERE

 

Merit Health Woman’s Hospital First In Mississippi To Offer Single-Dose Radiation Therapy For Treatment Of Breast Cancer

Posted January 22, 2021

Winston County Journal; Pelahatchie News; SW Rankin News – Mississippi

One-time treatment can eliminate up to six weeks of radiotherapy while reducing exposure to COVID-19.

View the full article HERE

 

Delaying cancer treatment amid COVID is creating a secondary public health crisis

Posted  January 17, 2021

Rome Sentinel – Rome, New York

COVID-19 has inadvertently caused substantial increases in the number of avoidable cancer deaths as a result of diagnostic and treatment delays.

View the full article HERE

How Good Shepherd treats breast cancer with just one dose of radiation

Posted December 30, 2020

Daily Herald – Arlington Heights, IL

Typically breast cancer patients go through several weeks of radiation.

 

View the full article HERE

Single-dose radiation therapy may lessen, eliminate unsafe additional outside trips during the pandemic

Posted December 14, 2020

News Medical Life Sciences – Manchester, UK

According to recent studies, an increase in the COVID-19 positivity rate correlates to an increase in mortality from non-coronavirus-related diseases. This includes breast cancer, and researchers believe fear of contracting the virus compels patients to stay home instead of completing their post-lumpectomy radiotherapy regimens.

View the full article HERE

Single-Dose Radiation Therapy At Time Of Lumpectomy Helps Breast Cancer Patients Overcome Treatment Challenges During Pandemic

TARGIT-IORT long-term data demonstrates equivalent outcomes to traditional 3- to 6-week radiotherapy, significantly reducing COVID-19 risk to patients amidst coming surge

Posted December 2, 2020

SACRAMENTO, Calif., (GLOBE NEWSWIRE) — The TARGIT Collaborative Group announced today that according to recent studies, an increase in the COVID-19 positivity rate correlates to an increase in mortality from non-coronavirus-related diseases. This includes breast cancer, and researchers believe fear of contracting the virus compels patients to stay home instead of seeking treatment or completing their many week course of post-lumpectomy radiotherapy.

 

View the full article HERE

Five Important Advances in Breast Cancer Treatment

Posted November 20, 2020

Managed Healthcare Executive – MHE Publication, MHE November 2020, Volume 30, Issue 11

Two newly approved antibody-drug conjugates and changes in radiation therapy lead the way.

Although there isn’t a cure for breast cancer, more effective treatments continue to emerge. Here’s a look at five developments for breast cancer treatment in the last two years.

View the full article HERE